首页> Oncoimmunology.> Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients

Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients

导出原文传递

翻译打印收藏纠错

第一作者： Baldin

作者： Baldin ^[1] ; P. ; Van den Eynde ; M. ; Mlecnik ; B. ; Galon ; J.

作者单位： Department of Pathology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain ^[1]

关键词 cancer classification chemotherapy immunity Immunoscore metastasis pathology prognosis stage IV tumor microenvironment

发布时间 2021-07-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Oncoimmunology.

2020年9卷1期

art. no. 1826133-art. no. 1826133页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Oncoimmunology.

2020年9卷1期

art. no. 1826133-art. no. 1826133页

检索历史清除

Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients

Oncoimmunology.

相似文献

同项目论文

Oncoimmunology.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients

Oncoimmunology.

相似文献

同项目论文

Oncoimmunology.

相关期刊

检索历史清除